Longevity News

Kenai wraps enrollment for REPLACE Parkinson’s trial

Source: Longevity Technology • Published: 28 Jul 2026, 16:37

Kenai wraps enrollment for REPLACE Parkinson’s trial

A preview of a news article about a donor-derived cell therapy trial finishing enrollment and what the milestone means for Parkinson’s research.

Key Takeaways
  • Parkinson’s treatment has largely followed the same playbook
  • Drugs such as Levodopa can dramatically improve symptoms, helping people regain movement and independence
  • Parkinson’s is typically diagnosed only after significant damage has already occurred
Read Original Source